Image

Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application

Standardising and Simplifying the Global Leadership Initiative on Malnutrition (GLIM) for Its More General Application

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

This observational study of aims to test whether and how the results of GLIM change when using different approaches and methods to carry out its components.

Description

The main questions the study aims to answer are:

  • What is the most effective pre-GLIM screening approach?
  • Which of the simple, globally accessible muscle mass measurement methods works the best in the context of GLIM?
  • How does using simpler approaches to screening and muscle mass measurement affect the performance of GLIM in detecting Subjective Global Assessment (SGA) defined malnutrition and 1-year mortality?

Participants will be/have:

  • asked questions about their recent food intake and possible non-volitional weight loss
  • assessed for malnutrition with SGA
  • weighed, and their height will be measured (if not already recorded)
  • their muscle mass measured with a measuring tape (mid-upper arm circumference and calf circumference) and bioelectrical impedance
  • their muscle function measured using hand grip strength
  • have their patient records looked at to extract their weight and height data (if present), diagnoses, routine blood test results, abdominal computed tomography (CT) scan (if present), dual-energy x-ray absorptiometry (DEXA) scan (if present), 1-year mortality and personal identification code for documentation (the latter will be deleted when the study period is over).

Eligibility

Inclusion Criteria:

  • Age of 18+ years
  • Able and willing to sign the consent form
  • Inpatients of the Tartu University Hospital
  • Admitted within 72 hours before enrolment

Exclusion Criteria:

  • Age of <18 years
  • Inability or refusal to sign the consent form
  • Pregnant or lactating women
  • More than 72 hours passed since admission
  • Patients isolating with an infection

Study details
    Malnutrition

NCT06164925

University of Tartu

28 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.